TellBio

Recent Finacing

Series A

Recent Raise

$5M

TellBio develops TellDx, a microfluidic diagnostic that detects live circulating tumor cells from liquid biopsies, and TellRx, a therapeutics program targeting CTCs, using MGH-licensed technology.

Founded 2019

Massachusetts, United States

1-10

Private

tellbio.com

Highlights

Focus Areas

Biotechnology

Health Care

Recent Investors

Financials

$5M

Total Raised

1

Funding round

4

Investors

Team

Upgrade to view the team

See the team members at TellBio.